Synergistic antitumor effect of anti-PDL1 combined with oxaliplatin on a mouse tumor model

被引：0
|
作者：
Rahimi, A. [1 ]
Alimohammadi, R. [2 ]
Jalali, S. A. [2 ]
Golchin, S. [2 ]
机构：
[1] Tarbiat Modares Univ, Immunol, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Immunol, Tehran, Iran
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LB070
引用
收藏
页码：1735 / 1736
页数：2
相关论文
共 50 条
  • [21] Heterogeneous tumor microenvironment in metastatic breast cancer for insufficient anti-PDL1 IgG delivery and its efficacy
    Liu, Yan Ting
    Goel, Shreya
    Kai, Megumi
    Thao Nguyen
    Yokoi, Kenji
    CANCER RESEARCH, 2021, 81 (04)
  • [22] Ceralasertib enhance efficacy of anti-PDL1 treatment by modulating the tumor microenvironment in a IFNAR I dependent manner
    Sanseviero, Emilio
    Taylor, Devon
    Tohumeken, Sehmus
    Mai, Mimi
    Mostafa, Ali
    Milo, Marta
    Mulgrew, Kathy
    Fuchs, Serge
    Lau, Alan
    Barry, Simon
    Cobbold, Mark
    Gabrilovich, Dmitry
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [23] Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer
    Guo, Zhiqiang
    Wang, Haolin
    Meng, Fandong
    Li, Jie
    Zhang, Shulan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [24] Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer
    Zhiqiang Guo
    Haolin Wang
    Fandong Meng
    Jie Li
    Shulan Zhang
    Journal of Translational Medicine, 13
  • [25] Radiotherapy Combined with PD-L1 Antibody Exerts a Synergistic Anti -tumor Effect in a Mouse Model of Esophageal Squamous Cell Carcinoma
    Yin, Z.
    Zhang, H.
    Zhang, K.
    Ying, H.
    Liu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E273 - E274
  • [26] A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of NSCLC
    Wright, M.
    Muthukumar, D.
    Badiger, R.
    LUNG CANCER, 2018, 115 : S36 - S36
  • [27] Predicting treatment outcome and enhancing immunotherapy with anti-PDL1 gold nanoparticles
    Meir, Rinat
    Shamalov, Katerina
    Cohen, Cyrille J.
    Popovtzer, Rachela
    REPORTERS, MARKERS, DYES, NANOPARTICLES, AND MOLECULAR PROBES FOR BIOMEDICAL APPLICATIONS XI, 2019, 10893
  • [28] Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors
    Chen, Jenny Ling-Yu
    Pan, Chun-Kai
    Huang, Yu-Sen
    Tsai, Ching-Yi
    Wang, Chun-Wei
    Lin, Yu-Li
    Kuo, Sung-Hsin
    Shieh, Ming-Jium
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) : 391 - 404
  • [29] Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors
    Jenny Ling-Yu Chen
    Chun-Kai Pan
    Yu-Sen Huang
    Ching-Yi Tsai
    Chun-Wei Wang
    Yu-Li Lin
    Sung-Hsin Kuo
    Ming-Jium Shieh
    Cancer Immunology, Immunotherapy, 2021, 70 : 391 - 404
  • [30] Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect
    Song, Xinran
    Jiang, Yuxin
    Zhang, Weixing
    Elfawal, Gomaa
    Wang, Kaili
    Jiang, Di
    Hong, Huoyan
    Wu, Jinglei
    He, Chuanglong
    Mo, Xiumei
    Wang, Hongsheng
    ACTA BIOMATERIALIA, 2022, 140 : 247 - 260
12345